NSAIDs, analgesics, antiplatelet drugs, and decline in renal function: a retrospective case-control study with SIDIAP database

We aim to explore the association between NSAIDs consumption, Symptomatic Slow Action Drugs for Osteoarthritis (SYSADOA), analgesics, and antiplatelet drugs, and decline in renal function by estimated Glomerular Filtration Rate (eGFR). We performed a case-control study using the SIDIAP database in C...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC pharmacology & toxicology 2024-08, Vol.25 (1), p.58, Article 58
Hauptverfasser: Bonet-Monné, Sara, Urgell, Cristina Vedia, Sáez, M José Pérez, Puertolás, Oriol Cunillera, Baena-Díez, José Miguel, Pascual, Julio, Lago, Cristina Orive, Ruiz, Jordi Rodriguez, Gonzalez, Betlem Salvador, Pedrós, Rosa Morros
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We aim to explore the association between NSAIDs consumption, Symptomatic Slow Action Drugs for Osteoarthritis (SYSADOA), analgesics, and antiplatelet drugs, and decline in renal function by estimated Glomerular Filtration Rate (eGFR). We performed a case-control study using the SIDIAP database in Catalonia. We considered defined cases, patients with an eGFR value ≤ 45 ml/min/1.73 m in the period 2010-2015 with a previous eGFR value ≥ 60, and no eGFR ≥ 60 after this period. Controls had an eGFR ≥ 60 with no previous eGFR 
ISSN:2050-6511
2050-6511
DOI:10.1186/s40360-024-00771-5